Steroid hormones are known to affect the humoral immune response to a variety of antigens. However, the mechanisms regulating these effects are poorly understood. The Experiments in male mice demonstrated that propanil increased the number of ASC comparable to female mice. However, orchiectomy did not inhibit this effect, suggesting that androgens do not regulate the amplification of the humoral response. These data suggest a novel role for the ovarian hormones in the regulation of the PC-specific antibody response.
INTRODUCTION
Numerous studies have characterized the immunomodulating effects of the steroid hormone 17 -estradiol (E2) on developing lymphocyte populations in the thymus and bone marrow and on the peripheral humoral immune response. Studies have demonstrated that E2 induces thymic atrophy through a Fas/FasL pathway dependent on both estrogen receptor (ER) and (Do et al., 2002; Erlandsson et al., 2001; Yao and Hou, 2004) . E2 treatment induces thymic atrophy primarily by decreasing the number of CD4 + CD8 + double positive thymocytes (Screpanti et al., 1989) . E2 also inhibits B lymphopoiesis in the bone marrow Islander et al., 2003) . Specifically, E2 decreases pro-B cell, pre-B cell, and mature B cells of the bone marrow in an ER and ER dependent manner .
Studies on the effects of E2 on specific immune responses have demonstrated that chronic exposure to E2 increases both the number of splenic antibody secreting cells (ASC) and the serum antibody titers to bacterial and autoantigens (Meyers and Petersen, 1985; Verthelyi and Ahmed, 1998) . Recent data suggest that E2 skews the genetic expression profile of B cells to enhance survival and to lower tolerance, which may contribute to the enhanced antibody response after E2 exposure (Frasor et al., 2003; Grimaldi et al., 2002) . It has been proposed that naturally occurring and synthetic compounds capable of acting through an estrogenic pathway may be able to induce the same immunomodulating effects as the endogenous hormone.
Reports on endocrine disrupting chemicals (EDC) that are known estrogen mimics demonstrate that these compounds induce similar immune enhancement as E2 (Sobel et al. 2005; 5 vaccine, the number of splenic ASC specific for PC is increased 4-6 fold over control animals (Salazar et al., 2005) . The current studies were designed to investigate the mechanism for the increase in PC antibody production following exposure to propanil.
Only limited studies have reported the endocrine disrupting effects of propanil. Using an in vitro luciferase reporter assay, propanil was found to be weakly anti-androgenic and lacked estrogenic receptor -and -binding activity (Kojima et al., 2004) . Another report found that the major metabolite of propanil, 3,4-dichloroaniline (3,4-DCA), binds the androgen receptor in vitro (Bauer et al., 1998) . Given the paucity of information describing the potential endocrine disrupting effects of propanil in vivo, one of the goals of this study was to better characterize propanil as an EDC, using both in vivo and in vitro models.
As described above, propanil induces a number of immunotoxic effects also caused by E2. The hypothesis for the present studies was that propanil increased the antibody response to HKSP vaccination through an estrogenic mechanism. The results demonstrate that propanil requires the ovaries and steroid synthesis to induce an increase in the antibody response in female mice. However, the experiments demonstrate that the enhanced antibody response following exposure to propanil occurs independently of the estrogen pathway. These studies suggest that the ovaries may regulate the systemic humoral immune response through a novel, estrogen-independent mechanism and that propanil modulates this pathway.
7 at 37°C on blood agar plates (Becton Dickinson). A few characteristic colonies were selected and suspended in 200 ml Todd-Hewitt broth + .05% yeast extract. Bacteria were grown at 37°C
to an absorbance reading at 650nm of 0.4 and heat killed for 4 hours in a 60°C water bath. A final concentration of 10 9 CFU/ml was established in PBS based on colony counts. Sterility was confirmed by culture. Heat-killed stock was stored at -20°C in 1 ml aliquots. Mice were immunized ip with 2x10 8 CFU. This dose of vaccine has previously been demonstrated to elicit an optimal PC-specific antibody response that peaks at day 7 post-vaccination (Wu et al., 1999; Wu et al., 2000) .
Animal exposures
Propanil was dissolved in p.o. for a final concentration of 15 mg/ml or 20 mg/ml for all experiments. For the experiments measuring antibody responses, mice (5/group) were treated ip with either 150 mg of propanil/kg of body weight (mg/kg) or vehicle on the same day as vaccination with heat-killed S. pneumoniae (HKSP). The dose of propanil was chosen based on previous studies that demonstrate an increase in the antibody response to PC in vaccinated mice at 150 mg/kg (Salazar et al., 2005) .
In experiments using E2, ovariectomized mice were injected sc with a daily dose of E2 (10 µg/kg). Animals received the first dose of E2 1 hr prior to herbicide or vehicle treatment and vaccination. Subsequent E2 treatments were given at the same time daily. Animals were sacrificed 24 hrs following the final E2 exposure.
In experiments using the ER antagonist, ICI 182,780 (10 mg/kg/day), was injected sc into female mice. Animals were treated with the first dose of ICI 1 hr prior to herbicide or vehicle exposure and vaccination. Subsequent ICI exposures were given at the same time daily throughout the course of the experiment.
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In experiments using the GnRH antagonist, antide (60 µg/mouse), female mice were injected sc every 48 hours 14 days prior to propanil or vehicle exposure and vaccination (Couse et al., 2003) . Subsequent antide treatments were given at the same time every 48 hours throughout the course of the experiment.
For the uterotrophic assays, OVX mice were treated with either a single ip injection of the vehicle or propanil (150 mg/kg), or 3 daily sc injections of E2 (10 µg/kg/day). Mice were euthanized 24 hours after the last E2 exposure, and the wet weights of the uteri were recorded.
In experiments using the progesterone receptor antagonist, RU486 (12.5 mg/kg), female mice were injected sc 2 hours prior to propanil treatment, 12 hours following propanil treatment, 
Serum estradiol levels
Serum estradiol levels were determined for mice treated with antide for 14 days using the Estradiol EIA kit (Diagnostic Automation Inc., Calabasas, CA), according to the kit instructions.
Briefly, serum samples collected from the saphenous vein or E2 standards were added to the provided 96-well microtiter plates coated with anti-E2 antibody. Anti-E2 antibody conjugated to peroxidase was added, and the wells were incubated for 90 min at room temperature. The wells were washed and substrate was added to each well for 20 min. The reaction was stopped and read at 450 nm with a µQuant spectrophotometer (Bio-Tek Instruments, Winooski, VT). The level of detection for the assay was 1 pg/ml.
Preparation of splenocytes
Mice were euthanized with 100 µl Nembutal Sodium Solution (50 mg/ml, Abbott
Laboratories, North Chicago, IL) on days 5 or 7 following herbicide exposure and vaccination.
Spleen wet weights were recorded. Spleens were mechanically dissociated through Spectra nylon mesh (Spectrum Labs, Rancho Dominguez, CA) in complete cell media containing RPMI-1640 (BioWhitaker, Walkersville, MD), 10% heat inactivated fetal bovine serum (FBS, Hyclone
Laboratories, Inc, Logan, UT), 10 mM HEPES (Sigma), 1 mM L-glutamine (Gibco, Rockville, MD), 5x10 -5 M 2-mercaptoethanol (Sigma), 100 U/ml penicillin (Gibco), and 100 µg/ml streptomycin (Gibco). Red blood cells in the spleen were lysed with Tris-buffered ammonium chloride. Cell suspensions were washed twice and counted using a hemacytometer. Viability was determined using Trypan blue dye exclusion. 
Measurement of antibody secreting B cells (ASC) in the spleen

Ishikawa cells and alkaline phosphatase activity
Ishikawa cells (a generous gift from Richard B. Hochberg, Yale University Medical School, New Haven, Connecticut) were maintained in MEM medium (Sigma), 10% fetal bovine serum, as described (Littlefield et al., 1990) . Ishikawa cells were treated as described to assess the effect of propanil on estrogen-inducible alkaline phosphatase (Littlefield et al., 1990) .
Briefly, cultures were rinsed twice with estrogen-free basal medium and maintained in this medium for 24 hours. Cells were then trypsinized and plated into 96 well plates (1x10
Statistics
One-way analysis of variance (ANOVA) was performed for all statistical analyses using a Tukey-Kramer t-test to perform multiple comparisons between all treatment groups. A significance level of p 0.05 was used for all tests. Statistical analysis was performed using JMP software (SAS Institute Inc., Cary, NC). All experiments were performed 3 or more times with similar results. The figures are representative data from one experiment.
RESULTS
Ovariectomization abrogates the antibody increase induced by propanil
To test the hypothesis that propanil increases the antibody response after vaccination with HKSP through an estrogenic mechanism, OVX or sham-operated mice were vaccinated with HKSP and treated with propanil or the vehicle. All sham-operated mice exposed to propanil had a significantly increased number of PC-specific ASC compared to sham-operated vehicle-treated mice ( Figure 1 ). PC-specific IgM and the dominant PC isotypes, IgG2b and IgG3, were significantly increased in propanil-treated animals ( Figure 1 ). Spleen cells from these mice were also cultured in vitro for 5 days and the production of antibody measured by specific ELISA.
There was an increase in antibody production that corresponded with the increase in ASC (data not shown). Ovariectomy abrogated the ability of propanil to increase the number of PC-specific 
Propanil does not bind to estrogen receptors in vivo or in vitro
To determine if propanil increased the PC antibody response by binding directly or indirectly with ER , in vivo uterotrophic assays were performed. OVX mice were treated once with 150 mg/kg of propanil. Positive control animals were treated daily with E2 (He et al., 2003) . Uterine weights were recorded 3 days following the first exposure. As expected, E2 treatment significantly increased uterine weight ( Figure 2 ). Propanil, however, did not increase the uterine weights compared to vehicle treated animals ( Figure 2 ). This data suggests that propanil does not directly or indirectly activate ER , which is primarily responsible for the E2-induced uterine proliferation (Weihua et al., 2000) . 
Administration of exogenous E2 does not restore the enhanced antibody response in
propanil-treated OVX mice.
To determine if propanil requires E2 to enhance the antibody response to HKSP, OVX mice were exposed once to either propanil or vehicle control. In addition, half of the propaniltreated and vehicle-treated OVX mice received daily sc E2 for 7 days. All groups were vaccinated with HKSP on day 0. The PC-specific responses from the OVX mice were compared with sham-operated mice. Uterine weights and PC-specific splenic ASC were measured on day 7. Uterine weights of OVX mice were significantly lower than sham-operated vehicle mice Figure 5B). These results suggest that the inability of propanil to enhance the antibody response in OVX mice was not due to the absence of E2.
An ER antagonist does not inhibit the ability of propanil to enhance the antibody response
The previous experiment demonstrated that the addition of exogenous E2 did not restore the ability of propanil to enhance the antibody response in OVX mice. However, it is possible that the dose of exogenous E2 given does not accurately mimic the level of E2 in mice with intact ovaries. To determine if signaling through the estrogen receptor is required for the increased immune response, mice were treated with the ER and ER antagonist ICI 182,780.
Normal female mice were vaccinated and treated with propanil or vehicle on day 0, and given daily treatments with ICI 182,780. Uterine weights were measured to confirm the efficacy of the ICI treatment and the PC-specific antibody response was determined. The uterine weights of all animals receiving the ER antagonist were significantly reduced compared to control animals ( Figure 6A ). Treatment with the ER antagonist did not affect the basal PC-specific ASC response in vehicle-treated mice (Vehicle vs. Vehicle + ICI, Figure 6B ). Propanil-exposed mice treated with ICI had an increased ASC response comparable to propanil alone (Propanil vs.
Propanil + ICI, Figure 6B ). These results demonstrate that the ER antagonist did not inhibit the increase in PC-specific ASC in propanil-treated animals, which suggests that signaling through the estrogen receptor pathway is not required for propanil to enhance the antibody response.
Inhibition of steroid synthesis in propanil-treated mice abrogates the increase in ASC
Chemical inhibition of steroid synthesis was conducted to determine if a gonadal steroid other than estradiol regulates the propanil amplification of the humoral immune response.
Animals were treated with the GnRH antagonist antide for 14 days prior to propanil exposure and HKSP vaccination to ensure complete suppression of ovarian steroid synthesis (Couse et al., 2003) . Serum estradiol levels were determined prior to propanil treatment on day 14. All mice had non-detectable levels of estradiol, which is indicative of the efficacy of the antide treatments (data not shown). Uterine weights and the immune response to PC were determined 7 days postvaccination. Antide-treated animals had significantly decreased uterine weights ( Figure 7A ).
Treatment with antide did not affect the basal PC-specific ASC response (Vehicle vs. Vehicle Antide, Figure 7B ). The number of PC-specific ASC in mice treated with antide and exposed to propanil were not significantly different from the vehicle controls (Vehicle vs. Propanil Antide, Figure 7B ), but were significantly different from the propanil-treated control animals that had an increased ASC response (Propanil vs. Propanil Antide, Figure 7B ). These results demonstrate that steroid synthesis is necessary for the enhanced immune response in the spleens of mice exposed to propanil.
A progesterone receptor antagonist does not inhibit antibody enhancement by propanil
Progesterone is another steroid hormone that has been shown to affect antibody production. The progesterone antagonist, RU486, was utilized to determine if progesterone signaling is required for the increased antibody response. As previously stated, propanil induces thymic atrophy which is partially inhibited by RU486 (de la Rosa et al., 2005) . To determine the efficacy of the RU486 treatments, mice were treated with RU486 2 hours prior to propanil or vehicle treatment, and at 12 and 24 hours post-exposure. RU486 partially abrogated thymic atrophy as determined by measurement of the thymic weights and by quantification of the CD4 + CD8 + thymocyte population ( Figure 8A and 8B), demonstrating that RU486 is efficacious via the sc route.
To determine if blockade of the progesterone receptor inhibits the increased antibody response, mice were injected with RU486 2 hours prior to propanil exposure and vaccination.
Mice were subsequently injected with RU486 12 hours post-exposure and every 24 hours following propanil treatment. Treatment with the progesterone antagonist did not affect the basal PC-specific ASC response in vehicle-treated mice (Vehicle vs. Vehicle + RU486, Figure 8C ).
Propanil-exposed mice treated with RU486 had an increased ASC response comparable to propanil alone (Propanil vs. Propanil + RU486, Figure 8C ). These results demonstrate that the progesterone antagonist did not inhibit the increase in PC-specific ASC in propanil-treated animals, which suggests that progesterone is not required for propanil to enhance the antibody response.
Propanil enhances the antibody response in both normal and orchiectomized males.
To determine if propanil increased the antibody response in a gender specific manner, male mice were vaccinated and treated with propanil or vehicle ( Figure 9 ). The PC-specific splenic ASC were measured after 7 days. Propanil increased the IgG2b, IgG3 and IgM PCspecific splenic ASC approximately 3-fold (Vehicle vs. Propanil, Figure 9 ). Castration did not significantly affect the propanil-induced increase in PC-specific ASC. Castrated males treated with propanil produced approximately the same fold increase in PC-specific ASC as normal propanil-treated male mice (Propanil vs. Propanil Castrated, Figure 9 ). These results suggest that androgens are not involved in the amplification of the immune response after propanil exposure. 
DISCUSSION
Increasing ER expression levels might also affect antibody activity since the ER is found on many immune cells including B cells (Grimaldi et al., 2002). Removal of E2 from circulation
would eliminate the ability of ER expressing cells to respond. However, subcutaneous administration of E2 to OVX mice failed to restore the stimulatory effect of propanil on the antibody response to HKSP, which indicates that propanil does not require the presence of E2 to exert its effect on the splenic antibody response. This also suggests that propanil exposure does not induce antibody stimulation by increasing the ability of cells to bind E2. In addition, the data shows that high concentrations of E2 for a short period of time (7 days impairing receptor dimerization, 2) increasing receptor degradation, thereby lowering ER expression, and 3) disrupting nuclear localization of the ER/ligand complex (Wakeling, 2000) . The classically studied source of GnRH is the hypothalamus, although it is unlikely that hypothalamic produced GnRH can directly affect spleen function since the concentration of GnRH in the portal blood is low and rapidly metabolized (Eskay et al., 1975) . Evidence suggests that the ligand for GnRH receptors on splenic lymphocytes is likely to be derived from another endogenous source and may act in an autocrine or paracrine fashion in non-pituitary organs (Chen et al., 1999) . Both GnRH mRNA and GnRH receptor mRNA are altered in splenocytes throughout the estrous cycle, however, the exact mechanism of this regulation is unknown (Jacobson et al., 1998) .
It is possible that the ovaries are involved in regulating the local GnRH production in the spleen, which contributes to the increased antibody response in propanil-treated animals. This hypothesis might also explain the contrasting results between castrated and ovariectomized animals. There is data which indicates that male and female discrepancies in immune function exist in response to GnRH treatment following gonadectomy (Jacobson et al., 1999) . These data suggest that the sexual disparities exist due to a residual effect caused by hormonal differences experienced early in development.
Additional evidence exists suggesting gonad-mediated hormone regulation in lymphocytes and the spleen. A recent report demonstrated that removal of the ovaries alters the activity of the steroid hormones aromatase and 17 -hydroxysteroid dehydrogenase locally in the spleens and T cells of mice (Samy et al., 2001 ). In addition, castration had the opposite effect on the activity of these enzymes (Samy et al., 2001 ). The role of these steroidogenic pathways in the spleen and T cells on the humoral immune response has not been evaluated. Propanil may act by disrupting the ovarian control of the steroidogenic enzymes in the spleen leading to altered B cell activation. Analyzing the local spleen-specific and ovary-specific hormone receptor mRNA, hormone mRNA, and the activity of steroid enzymes would yield valuable clues to the mechanism regulating this effect.
In contrast to the results presented here, previous studies have demonstrated that exposure to propanil can decrease the response to a T dependent and a T-independent antigen (Barnett et. al., 1992; Barnett and Gandy, 1989) . In the previous studies, C57Bl/6 female mice were exposed i.p. to propanil on day 0, immunized i.v. on day 3 with the TI-2 antigen DNPFicoll, or the T dependent antigen, SRBC, and the plaque-forming cell response in the spleen determined on day 7. In the present studies, propanil was administered i.p. on day 0 and the mice immunized i.p. with HKSP on day 0. The PC-specific ASC response was determined on day 7. It is possible that the different results between the studies in the PC antibody response is due to the nature of the antigen, purified antigen versus whole heat-killed bacteria. However, preliminary studies in the laboratory have demonstrated a similar enhancement of the ASC response to the TI-2 antigen PC-Ficoll when propanil is administered at the time of PC-Ficoll immunization. Therefore, the timing of propanil exposure and immunization may be the critical factor in the ultimate effect that propanil has on the humoral immune response. Preliminary studies demonstrate that propanil can be given 3 days after HKSP immunization and still enhance the PC immune response. In addition, preliminary experiments demonstrate that propanil can also enhance the ASC response in the spleen to a T dependent antigen on HKSP,
PspA. The PspA-specific serum antibody titers peak approximately 14 days post-immunization.
Propanil must be given on day 9 after immunization to enhance the PspA response. If the animals are exposed to propanil at the time of immunization on day 0 there is no effect on the immune response to PspA on day 14. Taken 
